UBE2M and digestive system neoplasm: As an ATP-competitive NAE inhibitor, mitoxantrone has high selectivity and inhibits the binding of UBE2M (also known as UBC12) to NEDD8, meanwhile, it can promote the apoptosis of gastrointestinal tumor cells by inhibiting the degradation of neddylation substrate p53 [94, 95].